Literature DB >> 31391342

An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.

Katherine Redinus1, Jin Hyen Baek2, Ayla Yalamanoglu2, Hye Kyung H Shin2, Radu Moldova3, Julie W Harral1, Delaney Swindle1, David Pak1, Scott K Ferguson1, Rachelle Nuss4, Kathryn Hassell4, Eva Nozik-Grayck1, Andre F Palmer5, Mehdi A Fini1, Vijaya Karoor1, Kurt R Stenmark1, Paul W Buehler2, David C Irwin1.   

Abstract

Circulating macrophages recruited to the lung contribute to pulmonary vascular remodeling in various forms of pulmonary hypertension (PH). In this study we investigated a macrophage phenotype characterized by intracellular iron accumulation and expression of antioxidant (HO-1), vasoactive (ET-1), and proinflammatory (IL-6) mediators observed in the lung tissue of deceased sickle cell disease (SCD) patients with diagnosed PH. To this end, we evaluated an established rat model of group 5 PH that is simultaneously exposed to free hemoglobin (Hb) and hypobaric hypoxia (HX). Here, we tested the hypothesis that pulmonary vascular remodeling observed in human SCD with concomitant PH could be replicated and mechanistically driven in our rat model by a similar macrophage phenotype with iron accumulation and expression of a similar mixture of antioxidant (HO-1), vasoactive (ET-1), and inflammatory (IL-6) proteins. Our data suggest phenotypic similarities between pulmonary perivascular macrophages in our rat model and human SCD with PH, indicating a potentially novel maladaptive immune response to concomitant bouts of Hb and HX exposure. Moreover, by knocking out circulating macrophages with gadolinium trichloride (GdCl3), the response to combined Hb and hypobaric HX was significantly attenuated in rats, suggesting a critical role for macrophages in the exacerbation of SCD PH.

Entities:  

Keywords:  Cardiovascular disease; Cell Biology; Vascular Biology; hypoxia

Mesh:

Substances:

Year:  2019        PMID: 31391342      PMCID: PMC6693838          DOI: 10.1172/jci.insight.127860

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  36 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.

Authors:  Maria A Cavasin; Kim Demos-Davies; Todd R Horn; Lori A Walker; Douglas D Lemon; Nicholas Birdsey; Mary C M Weiser-Evans; Julie Harral; David C Irwin; Adil Anwar; Michael E Yeager; Min Li; Peter A Watson; Raphael A Nemenoff; Peter M Buttrick; Kurt R Stenmark; Timothy A McKinsey
Journal:  Circ Res       Date:  2012-01-26       Impact factor: 17.367

3.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 4.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

5.  Extracellular hemoglobin polarizes the macrophage proteome toward Hb-clearance, enhanced antioxidant capacity and suppressed HLA class 2 expression.

Authors:  Theresa Kaempfer; Elena Duerst; Peter Gehrig; Bernd Roschitzki; Dorothea Rutishauser; Jonas Grossmann; Gabriele Schoedon; Florence Vallelian; Dominik J Schaer
Journal:  J Proteome Res       Date:  2011-04-14       Impact factor: 4.466

6.  Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.

Authors:  Joseph J Boyle; Michael Johns; Theresa Kampfer; Aivi T Nguyen; Laurence Game; Dominik J Schaer; Justin C Mason; Dorian O Haskard
Journal:  Circ Res       Date:  2011-11-03       Impact factor: 17.367

7.  Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity.

Authors:  Florence Vallelian; Christian A Schaer; Theresa Kaempfer; Peter Gehrig; Elena Duerst; Gabriele Schoedon; Dominik J Schaer
Journal:  Blood       Date:  2010-08-25       Impact factor: 22.113

Review 8.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

9.  Purification of hemoglobin by tangential flow filtration with diafiltration.

Authors:  Jacob Elmer; David R Harris; Guoyong Sun; Andre F Palmer
Journal:  Biotechnol Prog       Date:  2009 Sep-Oct

10.  The increase in pulmonary arterial pressure caused by hypoxia depends on iron status.

Authors:  Thomas G Smith; George M Balanos; Quentin P P Croft; Nick P Talbot; Keith L Dorrington; Peter J Ratcliffe; Peter A Robbins
Journal:  J Physiol       Date:  2008-10-27       Impact factor: 5.182

View more
  6 in total

Review 1.  Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease.

Authors:  Valentina Kon; Elaine L Shelton; Ashley Pitzer; Hai-Chun Yang; Annet Kirabo
Journal:  Curr Hypertens Rep       Date:  2022-06-21       Impact factor: 4.592

Review 2.  The impact of excessive salt intake on human health.

Authors:  Robert W Hunter; Neeraj Dhaun; Matthew A Bailey
Journal:  Nat Rev Nephrol       Date:  2022-01-20       Impact factor: 28.314

3.  Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Scott K Ferguson; Susan M Majka; Vijaya Karoor; Radu Moldovan; Chantal Sintas; Jennifer Black; Thomas Gentinetta; Raphael M Buzzi; Florence Vallelian; Andreas Wassmer; Monika Edler; Joseph Bain; Daniel Schu; Kathryn Hassell; Rachelle Nuss; Dominik J Schaer; David C Irwin
Journal:  Free Radic Biol Med       Date:  2021-08-31       Impact factor: 8.101

4.  Evidence supporting a role for circulating macrophages in the regression of vascular remodeling following sub-chronic exposure to hemoglobin plus hypoxia.

Authors:  Vijaya Karoor; Delaney Swindle; David I Pak; Derek Strassheim; Mehdi A Fini; Edward Dempsey; Kurt R Stenmark; Kathryn Hassell; Rachelle Nuss; Paul W Buehler; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-05       Impact factor: 3.017

5.  Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Mehdi A Fini; Kathryn Hassell; Rachelle Nuss; Rebecca B Wilkerson; Angelo D'Alessandro; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-07       Impact factor: 2.886

Review 6.  Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.

Authors:  Rani Ashouri; Madison Fangman; Alicia Burris; Miriam O Ezenwa; Diana J Wilkie; Sylvain Doré
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.